The Clorox Company (NYSE:CLX) Stock Holdings Trimmed by Mission Wealth Management LP

Mission Wealth Management LP lessened its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 1.5% in the first quarter, according to its most recent filing with the SEC. The firm owned 7,188 shares of the company’s stock after selling 109 shares during the quarter. Mission Wealth Management LP’s holdings in Clorox were worth $1,100,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Point72 Asset Management L.P. acquired a new position in shares of Clorox during the 4th quarter valued at $144,844,000. Norges Bank acquired a new position in Clorox during the fourth quarter worth about $128,382,000. Parsifal Capital Management LP acquired a new stake in Clorox in the 4th quarter valued at about $128,245,000. Confluence Investment Management LLC acquired a new stake in Clorox in the 1st quarter valued at about $135,630,000. Finally, International Assets Investment Management LLC boosted its position in shares of Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after purchasing an additional 481,725 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.6 %

NYSE CLX opened at $133.22 on Friday. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.14. The firm’s fifty day simple moving average is $135.62 and its 200-day simple moving average is $143.46. The company has a market capitalization of $16.54 billion, a PE ratio of 69.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.39.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.38. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business’s revenue was down 5.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.51 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Analyst Ratings Changes

CLX has been the subject of several recent research reports. Citigroup cut their target price on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Evercore ISI decreased their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a report on Wednesday, May 1st. Barclays reduced their target price on Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a report on Thursday, May 2nd. BNP Paribas began coverage on Clorox in a research note on Monday, June 24th. They issued an “underperform” rating and a $130.00 price target on the stock. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Five analysts have rated the stock with a sell rating and fourteen have given a hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $145.33.

Check Out Our Latest Stock Analysis on CLX

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.